Avanti Biosciences Inc
US UEI GZNJSM9ELXB3 · SME
8public awards
$10.4Mtotal public funding
2026-04-22latest award
State aid awards (8)
| Date | Amount | Type | Programme | Granted by |
|---|---|---|---|---|
| 2026-04-22 | $349k | Grant | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH | Department of Health and Human Services |
| 2026-03-17 | $3.3M | Grant | AGING RESEARCH | Department of Health and Human Services |
| 2023-08-01 | $349k | Grant | USE OF DYRK1A/B KINASE INHIBITORS FOR THE TREATMENT OF LIVER DISEASES | Department of Health and Human Services |
| 2022-09-30 | $3.4M | Grant | Development of DYRK1A allosteric modulator for the treatment of Alzhei | Department of Health and Human Services |
| 2019-07-01 | $449k | Grant | DYRK1A inhibitors as therapeutic approach to Tau hyper-phosphorylation | Department of Health and Human Services |
| 2019-05-15 | $1.7M | Grant | Development of DYRK1A allosteric modulator for the treatment of Alzhei | Department of Health and Human Services |
| 2018-08-01 | $299k | Grant | Development of novel prodrugs targeting Glutamate Dehydrogenase (GDH) | Department of Health and Human Services |
| 2017-08-15 | $583k | Grant | Development of DYRK A allosteric modulator for the treatment of Alzhei | Department of Health and Human Services |
Want an alert when companies like this one get funded in your sector? Pro waitlist →